| Issuer | % of Class | Filed |
|---|---|---|
|
Avalo Therapeutics, Inc.
13G/A
Amendment 2
AVTX · 05338F306
|
4.2% |
8/27/2025
Event 8/6/2025
|
|
iBio, Inc.
13G/A
Amendment 2
IBIO · 451033708
|
3.1% |
7/30/2025
Event 6/30/2025
|
|
iBio, Inc.
13G/A
Amendment 1
IBIO · 451033708
|
7.0% |
1/30/2025
Event 1/28/2025
|
|
iBio, Inc.
13G
IBIO · 451033708
|
7.2% |
1/29/2025
Event 1/28/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.